AB-402: Accelerated Wound Healing Via Electrotaxis
Chronic wounds, such as diabetic ulcers and pressure ulcers, annually affect more than 5.7 million Americans, placing an estimated burden of $20 billion on healthcare systems; however, there exists a lack of technologies addressing this need for effective and affordable chronic wound care treatment. CBE Professor Daniel Cohen is currently attempting to tackle this healthcare issue by developing a electricity-based wound-healing medical device. The self-regulated device harnesses the properties of electrotaxis to induce cell proliferation and migration towards the patient’s wound, thereby promoting the healing process. Alimtas worked with Professor Cohen to stress-test his medical device in the market, pitching his research to firms such as Trinity Life Sciences and Atlas Ventures in Boston.